Audited Supplier
Gosling Plague AntibodiesPlease Use under the Guidance of Veterinarian
(Generic Name)Gosling Plague Antibodies
(Trade name)E Beishu
(Main Ingredients)Mainly contains Gosling Plague virus antibody. AGP antibody titer ≥1:8.
(Effect and Usage)This product is used for treatment and urgent prevention of Gosling Plague.
(Administration and Dosage)Intramuscular injection or subcutaneous injection.
For urgent prevention: goslings of 1-day-old, 0.5ml each; 2~5-days-old, 0.5-0.8ml each.
For treatment: infected goslings, 1.0-1.5ml each.
(Side Effects)There is no observed adverse effect generally.
(Precautions)
1. The passive immunity protection period by this product for once injection is 5-7 days.
2. This product is not effective by oral application.
3. This product can be administered for multiple injections 2~3 times continuously.
4. This product has interference effect on gosling vaccine inoculation. It is forbidden to vaccinate gosling plague attenuated vaccines within seven days after application of this product.
5. The product can be injected together with antibiotics.
6. There is no influence to therapeutic effect if there is a little white precipitate at bottle bottom for long time storage.
(Specification)250ml/bottle, 500ml/bottle.
(Storage and Validity)Store at 2-8ºC and the validity from the production date is 18 months.
(Drug Approval No.)Veterinary Drug 150432118.
(GMP Certificate No.)(2019) Vet. Drug GMP No. 15020.
(Manufacturer)Shandong Sinder Technology Co., Ltd.
Country of Origin: China
Shandong Sinder Technology Co., Ltd ('Sinder') founded in April 1999, has a wide range of animal health products. Sinder focus on Animal Health Products, Animal Vaccine, Antibodies, Antibiotics, Feed Additives, Chinese Herbal Product, Pet food, Elisa, and PCR test kit.
Sinder always persists in the core concept of 'The Relentless Pursuit of Increasing Customer Value. ' Based on the animal health to achieve a service provider for ecological construction of agriculture and animal husbandry. Support the efficient and sustainable development of agriculture and animal husbandry. Make food safer and rural areas better!
Sinder is a high-tech enterprise and one of the top 10 veterinary drug manufacturers in China and focusing on the animal health business. At the moment, the company has 35 GMP production lines, 1 CNAS laboratory, 3 national scientific research platforms, and 8 provincial scientific research platforms owned by Sinder.
Sinder has 4 R&D centers located in Qingdao, Zhucheng, and Beijing, China, and 1 laboratory in Silicon Valley in the United States. At present, the company has 1,535 employees including more than 200 masters or above and 18 doctors. Also, the company established extensive technical cooperation with several domestic and foreign scientific research institutes, animal health companies, and domestic veterinary medicine enterprises. Sinder has undertaken 57 national, provincial, and ministerial projects, gained 7 provincial and ministerial science and technology progress awards, presided over or participated in 23 national standards, obtained 23 new veterinary drug certificates(one 1st class new drug), and 60 authorized patents.
